Related Experiment Video
Updated: Jan 16, 2026

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay
Published on: May 3, 2018
Dual Modes of Gene Regulation by CDK12
Yubao Wang1,2, Apoorva Baluapuri2,3,4, Cherubin Manokaran1,2
1Departments of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.
Abstract:
The process of transcription is driven forward by the activity of kinases including CDK7, CDK9 and CDK12. Accordingly, acute inhibition of any of these kinases results in profound downregulation of gene expression. Here, we discover that loss or inhibition of CDK12 also significantly upregulates a set of coding and non-coding loci, whose activation could contribute to the anti-proliferative effects of CDK12 inhibitors. Mechanistically, CDK12 inhibition impairs transcription elongation, leading to increased RNA polymerase II termination or arrest in long genes. However, short genes such as MYC and enhancer RNAs are highly transcribed in the absence of CDK12 activity. Indeed, in HER2+ breast cancer, a malignancy where CDK12 is co-amplified with HER2 and its expression correlates with disease status, CDK12 inhibition markedly elevates MYC expression to induce lethality. The dual effects of CDK12 inhibition elucidated herein clarify its role in transcriptional control and have significant translational implications.
Insights
CDK12 inhibition downregulates some genes but upregulates others, like MYC. This dual effect in cancer, particularly HER2+ breast cancer, clarifies CDK12
Area of Science:
- Molecular Biology
- Cancer Biology
- Gene Regulation
Background:
- Transcription is regulated by kinases, including Cyclin-Dependent Kinase 12 (CDK12).
- Kinase inhibition typically leads to gene expression downregulation.
Purpose of the Study:
- To investigate the complex effects of CDK12 inhibition on gene expression.
- To elucidate the role of CDK12 in transcriptional control and its implications in cancer.
Main Methods:
- Analysis of gene expression changes upon CDK12 inhibition.
- Investigating the impact on transcription elongation and termination.
- Studying CDK12's role in HER2+ breast cancer models.
Main Results:
- CDK12 inhibition causes both downregulation of long genes and upregulation of short genes, including MYC and enhancer RNAs.
- Impaired transcription elongation and increased RNA polymerase II termination/arrest observed in long genes.
- CDK12 inhibition elevates MYC expression in HER2+ breast cancer, leading to cell lethality.
Conclusions:
- CDK12 inhibition has dual effects on gene expression, impacting both transcription elongation and termination.
- The upregulation of specific genes like MYC contributes to the anti-proliferative effects of CDK12 inhibitors.
- Findings have significant translational implications for cancer therapy, especially in HER2+ breast cancer.
More Related Videos
Related Concept Videos
Inhibition of Cdk Activity
Positive Regulator Molecules
Positive Regulator Molecules
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Negative Regulator Molecules
S-Cdk Initiates DNA Replication
Two states at the origin of replication
In eukaryotes, the initiation of replication occurs at many sites on the chromosomes, called the origins of...

